Copyright: ©Author(s) 2026.
World J Clin Oncol. Nov 24, 2026; 17(11): 122944
Published online Nov 24, 2026. doi: 10.5306/wjco.122944
Published online Nov 24, 2026. doi: 10.5306/wjco.122944
Table 5 Multivariable Cox regression analyses for recurrence-free survival in different models
| Variables | HR comparison | Model 11 | Model 22 | Model 33 | Model 44 | ||||
| HR (95%CI) | MV P value | HR (95%CI) | MV P value | HR (95%CI) | MV P value | HR (95%CI) | MV P value | ||
| Age | > 60 years vs ≤ 60 years | - | - | - | - | - | - | - | - |
| Sex | Male vs female | NS | 0.256 | NS | 0.104 | NS | 0.104 | NS | 0.116 |
| Hypertension | Yes vs no | - | - | - | - | - | - | - | - |
| Diabetes mellitus | Yes vs no | - | - | - | - | - | - | - | - |
| Alcohol consumption | Yes vs no | - | - | - | - | - | - | - | - |
| ASA score | > 2 vs ≤ 2 | - | - | - | - | - | - | - | - |
| HBV (+) | Positive vs negative | NS | 0.922 | NS | 0.797 | NS | 0.797 | NS | 0.838 |
| Cirrhosis | Presence vs absence | 1.44 (1.25-1.66) | < 0.001 | 1.41 (1.22-1.63) | < 0.001 | 1.41 (1.22-1.63) | < 0.001 | 1.41 (1.22-1.63) | < 0.001 |
| Portal hypertension | Presence vs absence | NS | 0.315 | NS | 0.207 | NS | 0.207 | NS | 0.180 |
| Bilirubin | > 17.1 μmol/L vs ≤ 17.1 μmol/L | 1.21 (1.05-1.39) | 0.007 | 1.19 (1.04-1.37) | 0.013 | 1.19 (1.04-1.37) | 0.013 | 1.20 (1.04-1.38) | 0.011 |
| Preoperative ALT level | > 40 U/L vs ≤ 40 U/L | 1.25 (1.09-1.44) | 0.002 | 1.24 (1.08-1.43) | 0.003 | 1.24 (1.08-1.43) | 0.003 | 1.24 (1.07-1.43) | 0.003 |
| Preoperative AST level | > 40 U/L vs ≤ 40 U/L | NS | 0.975 | NS | 0.712 | NS | 0.712 | NS | 0.699 |
| Preoperative AFP level | > 400 μg/L vs ≤ 400 μg/L | NS | 0.069 | NS | 0.106 | NS | 0.106 | NS | 0.102 |
| Largest tumor diameter | > 5 cm vs ≤ 5 cm | 1.73 (1.51-1.98) | < 0.001 | 1.70 (1.48-1.95) | < 0.001 | 1.70 (1.48-1.95) | < 0.001 | 1.69 (1.48-1.94) | < 0.001 |
| Tumor number | Multiple vs solitary | 1.80 (1.51-2.14) | < 0.001 | 1.81 (1.52-2.15) | < 0.001 | 1.81 (1.52-2.15) | < 0.001 | 1.81 (1.52-2.16) | < 0.001 |
| Microvascular invasion | Yes vs no | 1.39 (1.22-1.59) | < 0.001 | 1.41 (1.24-1.61) | < 0.001 | 1.41 (1.24-1.61) | < 0.001 | 1.41 (1.24-1.61) | < 0.001 |
| Macrovascular invasion | Yes vs no | 2.89 (2.22-3.75) | < 0.001 | 2.83 (2.18-3.68) | < 0.001 | 2.83 (2.18-3.68) | < 0.001 | 2.85 (2.19-3.71) | < 0.001 |
| Satellites | Yes vs no | 1.96 (1.62-2.37) | < 0.001 | 1.95 (1.61-2.35) | < 0.001 | 1.95 (1.61-2.35) | < 0.001 | 1.95 (1.61-2.36) | < 0.001 |
| Poor tumor differentiation | Yes vs no | - | - | - | - | - | - | - | - |
| Incomplete tumor encapsulation | Yes vs no | 1.33 (1.14-1.56) | < 0.001 | 1.30 (1.11-1.52) | 0.001 | 1.30 (1.11-1.52) | 0.001 | 1.30 (1.11-1.52) | 0.001 |
| Intraoperative blood loss | > 400 mL vs ≤ 400 mL | 1.32 (1.10-1.57) | 0.003 | 1.30 (1.09-1.56) | 0.004 | 1.30 (1.09-1.56) | 0.004 | 1.30 (1.08-1.55) | 0.005 |
| Intraoperative transfusion | Yes vs no | NS | 0.245 | NS | 0.316 | NS | 0.316 | NS | 0.290 |
| Extent of liver resection | Major vs ≤ minor | NS | 0.143 | NS | 0.198 | NS | 0.198 | NS | 0.200 |
| Non-anatomical liver resection | Yes vs no | - | - | - | - | - | - | - | - |
| Resection margin | < 1 cm vs ≥ 1 cm | 1.29 (1.11-1.49) | 0.001 | 1.28 (1.11-1.49) | 0.001 | 1.28 (1.11-1.49) | 0.001 | 1.28 (1.10-1.48) | 0.001 |
| Preoperative albumin level | < 40 g/L vs ≥ 40 g/L | 1.19 (1.02-1.36) | 0.027 | - | - | NS | 0.411 | - | - |
| Preoperative prealbumin level | < 170 mg/L vs ≥ 170 mg/L | - | - | 1.30 (1.12-1.50) | 0.001 | 1.30 (1.12-1.50) | 0.001 | - | - |
| Albumin and prealbumin status | Group I vs | - | - | - | - | - | - | 1.00 | |
| Group II | - | - | - | - | - | - | 1.10 (0.89-1.36) | 0.359 | |
| Group III | - | - | - | - | - | - | 1.30 (1.06-1.60) | 0.014 | |
| Group IV | - | - | - | - | - | - | 1.33 (1.10-1.60) | 0.002 | |
- Citation: Shen HX, Song YS, Wang HF, Chen C, Song JK, Sun CG, Miao SZ, Chen XG, Bai SL, Zhao YF, Wang K. Comprehensive prognostic value of prealbumin and albumin in hepatocellular carcinoma resection: Insights from a Chinese multicenter cohort. World J Clin Oncol 2026; 17(11): 122944
- URL: https://www.wjgnet.com/2218-4333/full/v17/i11/122944.htm
- DOI: https://dx.doi.org/10.5306/wjco.122944